Prime Global, a recognised global leader in medical communications, evidence and access, and patient engagement, has acquired earthware, an award-winning creative digital agency that creates life-changing solutions to real world healthcare problems. earthware joins Prime Global in supporting pharma and biotech clients at every step of the healthcare journey; their industry-leading technology expertise will complement Prime Global’s scientific heritage and proven delivery, enhancing and expanding Prime Global’s existing digital capabilities.
At Prime Global, we are passionate about ensuring our operations are sustainable. We are proud to be working together with travel supplier Gray Dawes, in partnership with Forest Carbon, to provide our people with an international carbon offset programme for all business travel.
An estimated 57.4 million people live with dementia worldwide, (1) and unfortunately, clinical trials for dementia treatments have resulted in few pharmacotherapies – none of them curative. (2) (3) (4) For World Alzheimer’s Day, Prime Patient explore how Pharma can collaborate with people living with dementia to optimise the industry’s dementia research and patient community support.
The working day accounts for a lot of our time. On average, over a third of people’s days are spent at work. Because of this, it is extremely important we ensure we are spending this time in a place that is enjoyable and rewarding to work at.
Many agree that disability inclusion in clinical trials is a worthy pursuit, but the historical significance and future impact of pursuing this goal is relatively unexplored. Here, we peel back the layers of this vital mission.
At Prime Global, we are committed to supporting charities and causes that have a direct impact on our communities. This year, we organised the Prime Global Walking Challenge, a virtual walking challenge as part of our ESG initiative to help raise money for the Rainforest Action Network.
A very warm welcome to the latest cohort of our entry-level training programme, IGNITE. This marks the seventh round since the programme’s inception in 2017, and features trainees across our Medical Communications and Evidence, Access, and Patient practice areas.
This month, the results of the 2021 PatientView corporate reputation survey were released. With insights from 240 US patient groups, a number of key findings were reported; here, we take a closer look.
On May 24th, the Prime Patient teamwas fortunate to have a spot at 2022’s Patient Centricity and Engagement Conference, hosted in London, England. With a veritable smorgasbord of topics up for discussion, we were spoiled for choice! Here we summarise some highlights from the day, kicking off with tips on strengthening patient advocacy collaboration.
Haemophilia is a lifelong genetic disorder characterised by excessive bleeding.(1) Despite the existence of treatments for haemophilia, the condition continues to have major impacts on quality of life, for example in the areas of pain (acute and chronic), joint mobility, and physical function.(1) To mark World Haemophilia Day on 17 April, Prime Patient partnered with sister agency HCD Economics, a consultancy specialising in haemophilia patient research, and haemophilia advocate Laurence Woollard to better understand the existing relationship between patients and industry and how meaningful improvements can be made to the lives of people living with haemophilia (PwH).
Patient advocacy and engagement are important no matter the disease area, whether it’s a common condition or one that few have heard of. Following the recent celebration of Rare Disease Day, let’s take a closer look at patient engagement in rare mutation cancers.
Medical publishing is evolving beyond plain language summaries to provide insightful, patient-centred resourcesto change the course of pharmaceutical research for the better. For patients with rare diseases especially, this could be just what the doctor ordered, writes Olivia Kersey, Patient Engagement Strategist with Prime Patient.
To celebrate International Day of Women and Girls in Science, some of our brilliant women are sharing advice about achieving career goals, how they started their career in medcomms and their experience of being a woman of science.
This year’s ISMPP Europe meeting was action packed, with Prime Global sending 5 team members, presenting 5 posters, sharing 7 publication extenders, and moderating 2 roundtables! Here, we share some of our key highlights from the conference.
Olivia Kersey, Patient Engagement Strategist, outlines what we can learn from 2021 to optimise patient engagement strategy and implementation in 2022.
While there would be no such thing as the pharmaceutical industry without patients, it’s only in recent years that collaboration with patients has started to enter the mainstream. While 2021 was a good year for patient engagement, 2022 can be both bigger and better.
The Prime Patient team are proud to have had a poster accepted for presentation at the 2022 European meeting of ISMPP (International Society for Medical Publication Professionals), held virtually on 25-26 January. The poster, one of five accepted across Prime Global, presents the results of an internal survey that aimed to identify barriers and solutions to working with patient authors in medical publications.
Prime Global, a recognised global leader in medical communications and market access, has strengthened its Evidence, Access, and Patient Practice with the acquisition of HCD Economics, an academically aligned organisation focusing on health economics and outcomes research (HEOR) and real-world evidence (RWE). HCD will work closely with Prime Global’s highly experienced medical communications agencies and specialist consultancies, including market access consultancy, Prime Access, and patient engagement experts, Prime Patient, to deliver integrated evidence-led services.